New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report
Ischemic stroke is a complex multifactorial disorder. Anticoagulation is a growing research area, with the main goal of preventing systemic embolization and stroke. We report the case of a 41-year-old woman with antiphospholipid syndrome who was unsuccessfully treated with Dabigatran, a new oral ant...
Main Authors: | Francesca Antonia Arcadi, Simona Portaro, Roberto Giorgianni, Antonino Naro, Carmela Casella, Carmelo Genovese, Silvia Marino, Rocco Salvatore Calabrò |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Medicina |
Subjects: | |
Online Access: | http://www.mdpi.com/1010-660X/55/3/71 |
Similar Items
-
Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
by: Mu-Mei Hu, et al.
Published: (2017-04-01) -
The Anticoagulated trauma patient in the age of the direct oral anticoagulants: a Canadian perspective
by: Brendan Wood, et al.
Published: (2017-08-01) -
Incidence of Osteoporosis in Primary Care Patients with Atrial Fibrillation Receiving Different Oral Anticoagulants
by: Woldesellassie M. Bezabhe, et al.
Published: (2022-10-01) -
ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01) -
Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice
by: A. A. Zarudsky, et al.
Published: (2020-03-01)